Drugs and the hepatic porphyrias.
D000081:Acetamides / Q000009:adverse effects; D000622:Aminolevulinic Acid / Q000378:metabolism; D000818:Animals; D001463:Barbiturates / Q000009:adverse effects; D002415:Cats; D003997:Dicarbethoxydihydrocollidine / Q000009:adverse effects; D004285:Dogs; D006118:Griseofulvin / Q000009:adverse effects; D006418:Heme / Q000378:metabolism*; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000009:adverse effects; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007501:Iron / Q000009:adverse effects; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism; D011164:Porphyrias / Q000139:chemically induced / Q000378:metabolism*
D000081:Acetamides; D001463:Barbiturates; D006846:Hydrocarbons, Halogenated; D006993:Hypnotics and Sedatives; D006118:Griseofulvin; D006418:Heme; D003997:Dicarbethoxydihydrocollidine; D000622:Aminolevulinic Acid; D007501:Iron